To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in weekly mean of average pain score (last 7-day mean of past 24-hour average pain scores [NRS] in the pain diary) from baseline to Week 8 of the treatment period
Timeframe: Up to 15 weeks
Adverse Events
Timeframe: Up to 15 weeks